<!DOCTYPE html>
<html>

<head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, shrink-to-fit=no">
    <title>medidaily</title>
    <link rel="stylesheet" href="assets/bootstrap/css/bootstrap.min.css">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Lora">
    <link rel="stylesheet" href="assets/fonts/font-awesome.min.css">
    <link rel="stylesheet" href="assets/fonts/ionicons.min.css">
    <link rel="stylesheet" href="assets/css/Article-Clean.css">
    <link rel="stylesheet" href="assets/css/Article-List.css">
    <link rel="stylesheet" href="assets/css/best-carousel-slide.css">
    <link rel="stylesheet" href="assets/css/Customizable-Background--Overlay.css">
    <link rel="stylesheet" href="assets/css/Data-Table-1.css">
    <link rel="stylesheet" href="assets/css/Data-Table.css">
    <link rel="stylesheet" href="assets/css/Footer-Clean.css">
    <link rel="stylesheet" href="assets/css/Google-Style-Login.css">
    <link rel="stylesheet" href="https://cdn.datatables.net/1.10.15/css/dataTables.bootstrap.min.css">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/animate.css/3.5.2/animate.min.css">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/Swiper/3.3.1/css/swiper.min.css">
    <link rel="stylesheet" href="assets/css/Modern-Contact-Form.css">
    <link rel="stylesheet" href="assets/css/Navigation-with-Search.css">
    <link rel="stylesheet" href="assets/css/Projects-Horizontal.css">
    <link rel="stylesheet" href="assets/css/Simple-Slider.css">
    <link rel="stylesheet" href="assets/css/styles.css">
    <link rel="stylesheet" href="assets/css/Timeline.css">
</head>

<body>
    <nav class="navbar navbar-light navbar-expand-md navigation-clean-search">
        <div class="container"><a class="navbar-brand text-capitalize" href="index.html" style="background-image: url(&quot;assets/img/igGmU5m-removebg-preview.png&quot;);width: 144px;background-size: cover;height: 25px;margin: 27px;"></a><button data-toggle="collapse" class="navbar-toggler" data-target="#navcol-1"><span class="sr-only">Toggle navigation</span><span class="navbar-toggler-icon"></span></button>
            <div
                class="collapse navbar-collapse text-right text-sm-center" id="navcol-1">
                <ul class="nav navbar-nav text-left text-sm-left">
                    <li class="nav-item" role="presentation"></li>
                    <li class="nav-item" role="presentation"><a class="nav-link" href="index.html">Home</a></li>
                    <li class="nav-item" role="presentation"><a class="nav-link" href="sign.html">Sign-up</a></li>
                    <li class="nav-item" role="presentation"><a class="nav-link" href="about.html">About</a></li>
                    <li class="nav-item" role="presentation"><a class="nav-link" href="articles.html">Articles</a></li>
                </ul>
                <form class="form-inline ml-auto" target="_self">
                    <div class="form-group"><label for="search-field"><i class="fa fa-search" style="margin: 14px;"></i></label><input class="border rounded form-control search-field" type="search" id="search-field" name="search" style="background-color: #edebeb;margin: 0px;"></div>
                </form><a class="btn btn-light action-button" role="button" href="#" style="margin: 7px;">Search</a></div>
        <hr>
        </div>
    </nav>
    <div class="article-clean">
        <div class="container">
            <div class="row">
                <div class="col-lg-10 col-xl-8 offset-lg-1 offset-xl-2">
                    <div class="intro">
                        <h1 class="text-center">Global COVID-19 Vaccine summary: Side Effects</h1>
                        <p class="text-center"><span class="by">by</span> <a href="#">Putri</a><span class="date">May 25th, 2021</span></p><img class="img-fluid" src="assets/img/berita1_picture.jpg"></div>
                    <div class="text">
                        <p>Currently, in various areas of the world, 15 COVID-19 vaccines have been authorized for use. In this feature, we look at the types and their reported side effects.<br></p>
                        <p class="text-justify" style="color: rgb(0,0,0);"><br><em>All data and statistics are based on publicly available data at the time of publication. Some information may be out of date.&nbsp;Visit&nbsp;our&nbsp;</em><a href="https://www.medicalnewstoday.com/coronavirus">coronavirus</a>&nbsp;
                            <a
                                href="https://www.medicalnewstoday.com/coronavirus">hub</a>&nbsp;<em>and&nbsp;follow our&nbsp;</em><a href="https://www.medicalnewstoday.com/articles/live-updates-coronavirus-covid-19">live</a>&nbsp;<a href="https://www.medicalnewstoday.com/articles/live-updates-coronavirus-covid-19">updates page</a><em>&nbsp;for the most recent information on the COVID-19 pandemic.</em><br><br>As
                                the global effort to produce vaccines that can curb the COVID-19 pandemic forges ahead, headlines continue to highlight development breakthroughs and safety concerns.<br><br>This article summarizes the known side effects
                                of the&nbsp;<a href="https://covid19.trackvaccines.org/vaccines/">15</a>&nbsp;<a href="https://covid19.trackvaccines.org/vaccines/">authorized vaccines</a>&nbsp;and provides insight into risks that researchers are still
                                investigating.<br><br><em>Stay informed with&nbsp;</em><a href="https://www.medicalnewstoday.com/articles/live-updates-coronavirus-covid-19"><em>live</em></a><em>&nbsp;</em><a href="https://www.medicalnewstoday.com/articles/live-updates-coronavirus-covid-19"><em>updates</em></a><em>&nbsp;on the current COVID-19 outbreak and visit our&nbsp;</em>
                                <a
                                    href="https://www.medicalnewstoday.com/coronavirus"><em>coronavirus hub</em></a><em>&nbsp;for&nbsp;more advice on prevention and treatment.</em><br><br>Currently authorized COVID-19 vaccines<br><br>The table below gives an overview of the 15 authorized vaccines, categorized
                                    by&nbsp;<a href="https://www.medicalnewstoday.com/articles/how-do-covid-19-vaccines-work#Different-vaccine-types">type</a>,<br>based on how they function. It also shows their efficacy.<br><br>Each of the following vaccines
                                    has received use authorization in at least one country.<br><br><br>*TABEL*<br><br>* Covishield is the Oxford-AstraZeneca vaccine produced for India.<br><br>Common side effects<br><br>Vaccines allow the body to build
                                    immunity by activating T and B lymphocytes, cells that, respectively, recognize the targeted virus and produce antibodies to combat it.<br><br>A vaccine cannot cause COVID-19. No vaccine contains a complete form of
                                    the virus responsible for this illness.<br><br>While their body builds immunity, it is normal for a person to experience minor side effects.<br><br>According to the&nbsp;<a href="https://www.cdc.gov/coronavirus/2019-ncov/vaccines/expect/after.html">Centers for Disease Control and Prevention (CDC)Trusted Source</a>&nbsp;and
                                    the&nbsp;<a href="https://www.who.int/news-room/q-a-detail/coronavirus-disease-(covid-19)-vaccines-safety">World Health Organization (WHO)Trusted Source</a>, common side effects of a COVID-19 vaccine include:<br><br>-
                                    a fever<br>- fatigue<br>- headaches<br>- body aches<br>- chills<br>- nausea<br><br>A person might also experience side effects around the injection site, which is usually the upper arm. These might include swelling,
                                    pain, redness, an itchy rash, and other mild forms of irritation.<br><br><strong>Health authorities recognize that each of the 15 authorized&nbsp;COVID-19 vaccines can cause side effects. These are often mild and last for&nbsp;only a few days. They are not unexpected.</strong><br><br>Every
                                    vaccine facility in the United States has to report specific post-vaccination symptoms, known as adverse events, to the government’s Vaccine Adverse Event Reporting System (VAERS). Individuals can also submit reports
                                    through the&nbsp;<a href="https://vaers.hhs.gov/reportevent.html">VAERS</a>&nbsp;<a href="https://vaers.hhs.gov/reportevent.html">portal</a>.<br><br>The&nbsp;<a href="https://www.fda.gov/media/146269/download">Food</a>&nbsp;
                                    <a
                                        href="https://www.fda.gov/media/146269/download">and Drug Administration (FDA)Trusted Source</a>,&nbsp;<a href="https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/adverse-events.html">CDCTrusted Source</a>, and&nbsp;<a href="https://www.ema.europa.eu/en/documents/presentation/presentation-safety-monitoring-covid-19-vaccines-peter-arlett_en.pdf">other regulatory agencies</a>&nbsp;are
                                        closely monitoring VAERS to scrutinize the safety of the vaccines used in the U.S.<br><br>Similar systems are in place in other countries. In the United Kingdom, for example, the scheme is called&nbsp;<a href="https://www.sps.nhs.uk/articles/reporting-suspected-covid-19-vaccine-side-effects-product-defects-and-counterfeit-products/">Yellow Card</a>.
                                        The&nbsp;<a href="http://www.adrreports.eu/en/report_side_effect.html">European</a>&nbsp;<a href="http://www.adrreports.eu/en/report_side_effect.html">Union</a>&nbsp;asks people to report suspected side effects
                                        to their<br>healthcare practitioners or fill out dedicated online forms.<br><br><br>CORONAVIRUS NEWS<br><br>Allergic reactions and anaphylaxis&nbsp;<br><br>Rarely, a person experiences an allergic reaction to one
                                        or more of the ingredients in a vaccine. They might develop&nbsp;<a href="https://www.medicalnewstoday.com/articles/157260">hives</a>&nbsp;or another type of skin rash, swelling, and respiratory symptoms.<br><br>A
                                        severe allergic reaction can lead to&nbsp;<a href="https://www.medicalnewstoday.com/articles/216062">anaphylaxis</a>, and it involves low&nbsp;<a href="https://www.medicalnewstoday.com/articles/270644">blood</a>&nbsp;
                                        <a
                                            href="https://www.medicalnewstoday.com/articles/270644">pressure</a>, nausea, and difficulty breathing, among other symptoms.<br><br>Anaphylaxis is an extremely rare side effect of vaccination. According to the CDC, around&nbsp;<a href="https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/adverse-events.html">2–5 people per millionTrusted Source</a>,
                                            or fewer than 0.001% of people vaccinated in the U.S. have experienced anaphylaxis afterward.<br><br>Allergic reactions to mRNA vaccines have been of&nbsp;<a href="https://www.sciencemag.org/news/2020/12/suspicions-grow-nanoparticles-pfizer-s-covid-19-vaccine-trigger-rare-allergic-reactions">particular concern</a>,
                                            as they contain a&nbsp; chemical, called polyethylene glycol (PEG), that has never been used in a approved vaccine before. PEG is in many drugs that have occasionally triggered&nbsp; anaphylaxis. In these vaccines,
                                            it coats the mRNA molecule and supports penetration into cells.<br><br>There are similar concerns about the&nbsp;<a href="https://www.cdc.gov/vaccines/covid-19/info-by-product/janssen/downloads/Janssen-Prep-and-Admin-Summary.pdf">Janssen vaccineTrusted Source</a>,
                                            which contains&nbsp; polysorbate 80, a chemical that is structurally related to PEG.<br><br>A&nbsp;<a href="https://jamanetwork.com/journals/jama/fullarticle/2777417">studyTrusted Source</a>&nbsp;of data about
                                            allergic reactions to mRNA COVID-19 vaccines noted that most people who experienced anaphylaxis afterward had a history of allergies and this particular severe reaction.<br><br><strong>The data suggest that there is a very low risk of anaphylaxis as&nbsp;a result of mRNA COVID-19 vaccines. Regardless, the&nbsp;</strong>
                                            <a
                                                href="https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/specific-groups/allergies.html"><strong>CDCTrusted Source</strong></a><strong>&nbsp;recommend&nbsp;that vaccine administrators conduct prescreening for specific allergic&nbsp;reactions. These vaccines are safe for people with common allergies, such as to&nbsp;foods, pets, environmental elements, latex, and oral medications.</strong><br><br>The
                                                CDC also recommend that anyone who has had an allergic reaction to one dose of a vaccine not receive a second dose of the same type of vaccine.<br><br>Frequency of side effects in women<br><br>Side effects
                                                appear to be more commonly reported in women than men. A study by CDC researchers shows that&nbsp;<a href="https://www.cdc.gov/mmwr/volumes/70/wr/mm7008e3.htm">78.7%Trusted Source</a>&nbsp;of adverse event
                                                reports submitted during the first month of U.S. vaccination involved women.<br><br>Another study observed that females represented&nbsp;<a href="https://jamanetwork.com/journals/jama/fullarticle/2777417">15</a>&nbsp;
                                                <a
                                                    href="https://jamanetwork.com/journals/jama/fullarticle/2777417">out of 16Trusted Source</a>&nbsp;people with anaphylaxis after a vaccine.<br><br>These findings are in line with a&nbsp;<a href="https://www.sciencedirect.com/science/article/pii/S0264410X1301342X">2013 study</a>&nbsp;on
                                                    the&nbsp;<a href="https://www.medicalnewstoday.com/articles/147720">H1N1</a>&nbsp;vaccine during the 2009&nbsp;<a href="https://www.medicalnewstoday.com/articles/15107">flu</a>&nbsp;pandemic, which found
                                                    higher rates of hypersensitivity reactions among females of childbearing age than other groups in the study population.<br><br>Reproductive hormones, such as&nbsp;<a href="https://www.medicalnewstoday.com/articles/277177">estrogen</a>&nbsp;and&nbsp;
                                                    <a
                                                        href="https://www.medicalnewstoday.com/articles/276013">testosterone</a>, may play a role in this sex discrepancy. A&nbsp;<a href="https://www.nature.com/articles/s41541-019-0124-6">studyTrusted Source</a>&nbsp;in mice suggests that estrogen causes the body
                                                        to generate more antibodies, heading to a higher immune response.<br><br>Potential side effects per vaccine<br><br>Recently, there have been new concerns about serious side effects of COVID-19 vaccines.<br><br>These
                                                        effects may be coincidental, and there is currently not enough conclusive evidence to link these effects to specific vaccines. However, regulatory agencies are taking precautionary measures to investigate
                                                        these safety concerns.<br><br>Pfizer-BioNTech and Moderna<br><br>The Pfizer-BioNTech and Moderna vaccines are both two-dose&nbsp;<a href="https://www.medicalnewstoday.com/articles/how-do-mrna-vaccines-work">mRNA</a>&nbsp;
                                                        <a
                                                            href="https://www.medicalnewstoday.com/articles/how-do-mrna-vaccines-work">vaccines</a>. People have reported similar, common side effects after the second doses of each.<br><br>These COVID-19 vaccines are the first vaccines approved for use in humans that incorporate mRNA
                                                            technology. As a result, there are concerns about the long-term effects and a risk of altering the body’s genetic information.<br><br>People may be unaware that researchers have spent many years
                                                            studying the potential of mRNA vaccine technology. There have been efforts to develop mRNA vaccines in the past, including Moderna’s human-based&nbsp;<a href="https://investors.modernatx.com/news-releases/news-release-details/moderna-highlights-opportunity-mrna-vaccines-its-first-vaccines">trial</a>&nbsp;of
                                                            an mRNA&nbsp;<a href="https://pubmed.ncbi.nlm.nih.gov/27029595/">Zika</a>&nbsp;<a href="https://pubmed.ncbi.nlm.nih.gov/27029595/">virusTrusted Source</a>&nbsp;vaccine.<br><br>Furthermore, it
                                                            is unlikely that an mRNA vaccine can alter genetic information. The mRNA in a vaccine does not enter the nucleus of a&nbsp; cell, where DNA is stored, and it degrades rather quickly in the body
                                                            after it serves its purpose.<br><br><strong>Yet many were alarmed by reports from Norway that&nbsp;</strong><a href="https://www.bmj.com/content/372/bmj.n149"><strong>23</strong></a><strong>&nbsp;</strong>
                                                            <a
                                                                href="https://www.bmj.com/content/372/bmj.n149"><strong>peopleTrusted Source</strong></a><strong>&nbsp;had died shortly&nbsp;after receiving the Pfizer-BioNTech vaccine. However, there is no evidence that&nbsp;these deaths were a direct result of the vaccine.</strong><br><br>“There
                                                                is a possibility that these common adverse reactions — that are not dangerous in fitter, younger patients and are not unusual with vaccines —may aggravate underlying disease in the elderly,”
                                                                suggests Dr. Steinar Madsen, the medical director of the Norwegian Medicines Agency.<br><br>“We are now asking for doctors to continue with the vaccination, but to carry out extra evaluation
                                                                of very sick people whose underlying condition might be aggravated by it,” he adds.<br><br>Another death, which occurred in the U.S., was associated with having a low blood platelet count,
                                                                or&nbsp;<a href="https://www.nhlbi.nih.gov/health-topics/thrombocytopenia">thrombocytopeniaTrusted Source</a>. So far,&nbsp;<a href="https://onlinelibrary.wiley.com/doi/10.1002/ajh.26132?af=R">20 thrombocytopenia casesTrusted Source</a>&nbsp;have
                                                                developed following either a Pfizer or Moderna vaccination. Currently, however, no causal evidence links these cases with the vaccines.<br><br>Other concerns involve pregnancy and fertility.
                                                                According to a February 2021&nbsp;<a href="https://www.acog.org/news/news-releases/2021/02/medical-experts-assert-covid-vaccines-do-not-impact-fertility">statement</a>&nbsp;from the American
                                                                College of Obstetricians and Gynecologists, the American Society for Reproductive Medicine, and the Society for Maternal-Fetal Medicine:<br><br>“While fertility was not specifically studied
                                                                in the clinical trials of the vaccine, no loss of fertility has been reported among trial participants or among the millions who&nbsp; have received the vaccines since their authorization,
                                                                and no signs of infertility appeared in animal studies. Loss of fertility is scientifically unlikely.”<br><br>In a&nbsp;<a href="https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-commence-global-clinical-trial-evaluate">press statement</a>&nbsp;later
                                                                the same month, Pfizer and BioNTech announced that they have begun a COVID-19 vaccine clinical trial in 4,000 healthy pregnant women to explore the efficacy and safety for<br>the participants
                                                                and their babies. The results will hopefully provide further insight.<br><br>Janssen (Johnson &amp; Johnson)<br><br>The Janssen vaccine can also cause common vaccine side effects.<br><br>The
                                                                vaccine’s product information&nbsp;<a href="https://www.ema.europa.eu/en/documents/product-information/covid-19-vaccine-janssen-epar-product-information_en.pdf">document</a>&nbsp;provides
                                                                details about precautions to take and the expected effects.<br><br>Following&nbsp;<a href="https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-04-23/03-COVID-Shimabukuro-508.pdf">reportsTrusted Source</a>&nbsp;of
                                                                eight cases of thrombosis with thrombocytopenia syndrome (TTS), a rare and severe blood clotting disorder and low blood platelet counts, the CDC and the FDA briefly&nbsp;<a href="https://www.cdc.gov/media/releases/2021/s0413-JJ-vaccine.html">recommendedTrusted Source</a>&nbsp;pausing
                                                                the distribution of the Janssen COVID-19 vaccine in April 2021.<br><br>After conducting a safety review, the two federal agencies&nbsp;<a href="https://www.fda.gov/news-events/press-announcements/fda-and-cdc-lift-recommended-pause-johnson-johnson-janssen-covid-19-vaccine-use-following-thorough">liftedTrusted Source</a>&nbsp;the
                                                                recommended pause, concluding that the vaccine’s “known and potential benefits outweigh its known and potential risks in individuals 18 years of age and older” and that the risk of TTS after
                                                                vaccination was “very low.”<br><br>However, they advised that healthcare professionals and vaccine recipients should familiarize themselves with the revised&nbsp;<a href="https://www.fda.gov/media/146304/download"><em>Janssen</em></a><em>&nbsp;</em>
                                                                <a
                                                                    href="https://www.fda.gov/media/146304/download"><em>COVID-19 Vaccine Fact Sheet for Healthcare Providers Administering Vaccine</em></a><em>&nbsp;</em><a href="https://www.fda.gov/media/146304/download"><em>(Vaccination Providers)Trusted Source</em></a>&nbsp;and&nbsp;
                                                                    <a
                                                                        href="https://www.fda.gov/media/146305/download"><em>Fact</em></a><em>&nbsp;</em><a href="https://www.fda.gov/media/146305/download"><em>Sheet for Recipients and CaregiversTrusted Source</em></a>, which now include information on the
                                                                        risk of TTS.<br><br>The European Medicines Agency’s (EMA) safety committee also&nbsp;<a href="https://www.ema.europa.eu/en/news/covid-19-vaccine-janssen-ema-finds-possible-link-very-rare-cases-unusual-blood-clots-low-blood">advised</a>&nbsp;Janssen
                                                                        to include a warning about TTS in the product information for their COVID-19 vaccine.<br><br>Oxford-AstraZeneca and Serum Institute of India<br><br>The EMA and Danish Health Authority
                                                                        observed that the Oxford-AstraZeneca vaccine has been followed by incidents of blood clots.<br><br>Of the 5 million people who received this vaccine, there have been&nbsp;<a href="https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-prac-investigating-cases-thromboembolic-events-vaccines-benefits">30 reported cases</a>&nbsp;of
                                                                        blood clots. One case in Denmark was followed by death.<br><br>On April 7, 2021, the&nbsp;<a href="https://www.ema.europa.eu/en/news/astrazenecas-covid-19-vaccine-ema-finds-possible-link-very-rare-cases-unusual-blood-clots-low-blood">EMA</a>&nbsp;concluded
                                                                        that the Oxford-AstraZeneca vaccine should carry a warning of TTS as a very rare side effect.<br><br>Multiple countries, including Denmark, Norway, Germany, and France, initially&nbsp;
                                                                        <a
                                                                            href="https://www.bbc.com/news/world-europe-56357760">paused</a>&nbsp;<a href="https://www.bbc.com/news/world-europe-56357760">the distribution</a>&nbsp;of the Oxford-AstraZeneca COVID-19 vaccine as a precautionary response to initial
                                                                            reports of blood clots. On April 14, 2021, Denmark&nbsp;<a href="https://www.reuters.com/world/europe/world-first-denmark-ditches-astrazenecas-covid-19-shot-2021-04-14/">decided</a>&nbsp;to
                                                                            stop the distribution of this vaccine entirely.<br><br>On April 15, the Norwegian Institute of Public Health&nbsp;<a href="https://www.reuters.com/world/europe/norway-should-exclude-jj-astrazeneca-covid-vaccination-scheme-says-commission-2021-05-10/">recommended</a>&nbsp;stopping
                                                                            the distribution of both the Oxford-AstraZeneca and Janssenvaccines in the country, due to the risk of blood clots.<br><br>Both&nbsp;<a href="https://www.reuters.com/world/europe/third-wave-pandemic-appears-be-broken-german-health-minister-2021-05-07/">Germany</a>&nbsp;and&nbsp;
                                                                            <a
                                                                                href="https://www.reuters.com/world/europe/i-dont-want-that-france-struggles-pitch-astrazeneca-vaccine-2021-04-19/">France</a>&nbsp;have resumed administering the Oxford-AstraZeneca COVID-19 vaccine. However, the distribution may eventually halt altogether, as the EU&nbsp;<a href="https://www.reuters.com/world/europe/eus-breton-eu-did-not-renew-astrazeneca-covid-19-vaccine-order-after-june-2021-05-09/">has not renewed</a>&nbsp;its
                                                                                order of Oxford-AstraZeneca vaccine doses beyond June 2021.<br><br><strong>The Serum Institute of India’s Covishield is the locally&nbsp;manufactured version of the Oxford-AstraZeneca vaccine. India has&nbsp;</strong>
                                                                                <a
                                                                                    href="https://www.businessinsider.in/science/health/news/astrazeneca-covid-19-vaccine-controversy-from-india-to-europe/articleshow/81527932.cms"><strong>not reported</strong></a><strong>&nbsp;any incidents of&nbsp;blood clotting related to Covishield and currently has no plans to discontinue&nbsp;its distribution.</strong><br><br>Drug
                                                                                    regulatory agencies in India are still closely examining the data, however, to ensure that there are no causal links.<br><br>CanSino and Gamaleya<br><br>Both the&nbsp;
                                                                                    <a
                                                                                        href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31605-6/fulltext">CanSinoTrusted Source</a>&nbsp;and&nbsp;<a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00234-8/fulltext#seccestitle150">GamaleyaTrusted Source</a>&nbsp;vaccines
                                                                                        use the adenovirus type-5 (Ad5) as their delivery vehicle. The&nbsp;<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553041/">peer-reviewed</a>&nbsp;<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553041/">researchTrusted Source</a>&nbsp;into
                                                                                        trials of these vaccines found that they caused common side effects, none of which were serious.<br><br>However, a team that included Dr. Juliana McElrath, director
                                                                                        of the Vaccine and Infectious Disease Division at the Fred Hutchinson Cancer Research Center,&nbsp;<a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32156-5/fulltext">raised concernsTrusted Source</a>&nbsp;about
                                                                                        the use of Ad5 in COVID-19 vaccines.<br><br>A&nbsp;<a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(08)61591-3/fulltext">2008 studyTrusted Source</a>&nbsp;found
                                                                                        that the Ad5 HIV-1 vaccine was linked to increased susceptibility to HIV infection. Multiple&nbsp;<a href="https://pubmed.ncbi.nlm.nih.gov/19925902/">follow-up studiesTrusted Source</a>&nbsp;found
                                                                                        simila results to support this link.<br><br>The researchers recommend a cautious approach to Ad5-based COVID-19 vaccines, especially in areas most affected by the
                                                                                        HIV and&nbsp;<a href="https://www.medicalnewstoday.com/articles/17131">AIDS</a>&nbsp;epidemic.<br><br>Bharat Biotech<br><br>Published&nbsp;<a href="https://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2821%2900070-0/fulltext">dataTrusted Source</a>&nbsp;from
                                                                                        Bharat Biotech’s Covaxin phase 1 and 2 trials show no serious side effects. Otherwise, there is little information about the risk of adverse effects.<br><br>Sinopharm:
                                                                                        Beijing and Wuhan<br><br>Sinopharm have manufactured two vaccines, developed with the Institute of Biological Products in Beijing and Wuhan, respectively.<br><br><br>The
                                                                                        published phase 1 and 2 trial data for the&nbsp;<a href="https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30831-8/fulltext">BBIBP-CorVTrusted Source</a>&nbsp;and&nbsp;
                                                                                        <a
                                                                                            href="https://pubmed.ncbi.nlm.nih.gov/32789505/">inactivated</a>&nbsp;<a href="https://pubmed.ncbi.nlm.nih.gov/32789505/">Vero cellTrusted Source</a>&nbsp;vaccines show that most of the adverse events were common
                                                                                            side effects and that none were serious.<br><br>Sinovac<br><br>Phase 1 and 2&nbsp;<a href="https://www.thelancet.com/article/S1473-3099(20)30843-4/fulltext">trial dataTrusted Source</a>&nbsp;for
                                                                                            the CoronaVac vaccine indicate no reports of serious adverse events.<br><br><br>Interestingly, the study authors found fewer reports of&nbsp;<a href="https://www.medicalnewstoday.com/articles/168266">fever</a>&nbsp;among
                                                                                            participants who received this vaccine, compared with those who had received the Pfizer-BioNTech, Oxford-AstraZeneca, or CanSino vaccines.<br><br>CoviVac and QazCovid-in<br><br>There
                                                                                            is currently no internationally available information on the possible side effects of either the&nbsp;<a href="https://www.dw.com/en/two-more-russian-vaccines-what-we-do-and-dont-know/a-56811025">CoviVac</a>&nbsp;or&nbsp;
                                                                                            <a
                                                                                                href="https://www.rferl.org/a/kazakhstan-qazvac-vaccine-worries-research-trials-covid/31240883.html">QazCovid-in</a>&nbsp;vaccine.<br><br>As far as QazCovid-in is concerned, its developers have reassured the public that “the vaccine is harmless.” When asked about
                                                                                                the lack of published data regarding the vaccine, they alleged that they “don’t have time […] to write articles.”<br><br>Anhui Zhifei Longcom<br><br>There
                                                                                                is currently no publicly available peer-reviewed data about the safety or efficacy of the dimeric receptor-binding domain, or RBD-dimer, vaccine. One&nbsp;
                                                                                                <a
                                                                                                    href="https://www.medrxiv.org/content/10.1101/2020.12.20.20248602v1">preprint paper</a>&nbsp;states that no serious adverse events were reported during a trial.<br><br>FBRI<br><br>EpiVacCorona is Russia’s second approved COVID-19
                                                                                                    vaccine, and trials to determine its safety and efficacy are ongoing.<br><br>Tatyana Golikova, the country’s deputy prime minister,&nbsp;<a href="https://www.precisionvaccinations.com/vaccines/epivaccorona-vaccine">notes</a>:
                                                                                                    “Unlike the first Russian vaccine, Sputnik V, which is a vector vaccine, that is, produced based on adenovirus, the new vaccine […] consists of artificially
                                                                                                    synthesized short fragments of viral proteins, peptides, through which the immune system learns and subsequently recognizes and neutralizes the virus.”<br><br>Should
                                                                                                    I receive a COVID-19 vaccine?<br><br>Any form of medical treatment carries risks, but in many cases, these are outweighed by the benefits. The&nbsp;
                                                                                                    <a
                                                                                                        href="https://www.cdc.gov/vaccines/covid-19/info-by-product/clinical-considerations.html#Contraindications">CDCTrusted Source</a>&nbsp;recommend that people get vaccinated to curb the spread of the virus that causes COVID-19,except in very specific circumstances.<br><br>Receiving
                                                                                                        a vaccine does not guarantee full protection against COVID-19. People must continue to follow social distancing guidelines, wear a mask in public,
                                                                                                        and wash their hands frequently, among other precautions.<br><br>Meanwhile,&nbsp;<a href="https://www.nature.com/articles/s41591-021-01230-y">more</a>&nbsp;
                                                                                                        <a
                                                                                                            href="https://www.nature.com/articles/s41591-021-01230-y">than 50Trusted Source</a>&nbsp;other COVID-19 vaccines are currently in phase 1–3 clinical trials. With new progress being reported every day, much
                                                                                                            of the world is beginning to look toward a future beyond the COVID-19 pandemic.<br><br><br><br></p>
                        <h2></h2>
                        <p></p>
                        <figure>
                            <figcaption></figcaption>
                        </figure>
                        <p></p>
                    </div>
                </div>
            </div>
        </div>
    </div>
    <div class="footer-clean">
        <footer>
            <div class="container">
                <div class="row justify-content-center">
                    <div class="col-lg-3 text-center item social"><a href="#"><i class="icon ion-social-facebook"></i></a><a href="#"><i class="icon ion-social-twitter"></i></a><a href="#"><i class="icon ion-email"></i></a><a href="#"><i class="icon ion-social-instagram"></i></a>
                        <p class="text-center copyright">MediDailyID © 2021</p>
                    </div>
                </div>
            </div>
        </footer>
    </div>
    <script src="assets/js/jquery.min.js"></script>
    <script src="assets/bootstrap/js/bootstrap.min.js"></script>
    <script src="https://cdn.datatables.net/1.10.15/js/jquery.dataTables.min.js"></script>
    <script src="https://cdn.datatables.net/1.10.15/js/dataTables.bootstrap.min.js"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/Swiper/3.3.1/js/swiper.jquery.min.js"></script>
    <script src="assets/js/Simple-Slider.js"></script>
</body>
</html>